Cyber Threat to Healthcare and Pharma in times of Covid-19: Strategy vs. Tactical Approach
Cyber Threat to Healthcare and Pharma in times of Covid-19: Strategy vs. […]
Cyber Threat to Healthcare and Pharma in times of Covid-19: Strategy vs. […]
Evolving cyber threats in the Covid-19 era by Danilo Maruccia, Partner & […]
New EU GMP Vol.4 Annex I and Environmental Monitoring leverage by: Alessio […]
How to perform a robust Vaccine Technology Transfer in a challenging era
Operational Technology and Cyber Security must walk hand in hand by Danilo Maruccia […]
Impact of possible removal of the Titanium dioxide from human medicines formulations […]
5 questions (plus, a bonus one) you should be able to answer […]
Technology Transfer has always been a hot topic and can be even more challenging for complex processes/products like biotechnological ones.
In this Covid-19 pandemic era, different companies are facing technology transfer processes as a mandatory way to boost their covid vaccines production and follow patients’ need, shifting a series of contract manufacturers across the world that must inherit their technology and achieve compliance in a really short timing to meet the production goals.
Pharmacovigilance Data: challenges for Pharmaceutical Companies by: Daniela Rota PV Unit Manager […]
GDPR: 3 years later What we learned and what we need to […]